The Journal of Allergy and Clinical Immunology
Volume 118, Issue 5 , Pages 1075-1081 , November 2006

Small airways response to naturalistic cat allergen exposure in subjects with asthma

  • Michelle R. Zeidler, MD, MS

      Affiliations

    • From the Divisions of Pulmonary, Critical Care Medicine and Hospitalists
    • ,
  • Jonathan G. Goldin, MD, PhD

      Affiliations

    • Thoracic Radiology, David Geffen School of Medicine
    • ,
  • Eric C. Kleerup, MD

      Affiliations

    • From the Divisions of Pulmonary, Critical Care Medicine and Hospitalists
    • ,
  • Hyun J. Kim, MS

      Affiliations

    • Thoracic Radiology, David Geffen School of Medicine
    • ,
  • Dao A. Truong, BS

      Affiliations

    • Thoracic Radiology, David Geffen School of Medicine
    • ,
  • David W. Gjertson, PhD

      Affiliations

    • Thoracic Radiology, David Geffen School of Medicine
    • ,
  • Nola J. Kennedy, PhD

      Affiliations

    • School of Public Health, University of California, Los Angeles
    • ,
  • Kenneth B. Newman, MD

      Affiliations

    • Forest Laboratories, New York
    • ,
  • Donald P. Tashkin, MD

      Affiliations

    • From the Divisions of Pulmonary, Critical Care Medicine and Hospitalists
    • ,
  • Jeffrey M. Silverman, MD

      Affiliations

    • Keck School of Medicine at the University of Southern California and Landmark Imaging
    • ,
  • Jonathan Corren, MD

      Affiliations

    • Division of Clinical Immunology and Allergy, David Geffen School of Medicine and Allergy Research Foundation
    • Corresponding Author InformationReprint requests: Jonathan Corren, MD, Allergy Research Foundation, 11620 Wilshire Blvd, Suite 200, Los Angeles, CA 90025.

Received 24 April 2006 ,Revised 21 June 2006 ,Accepted 22 June 2006.

References 

  1. Tashkin DP. The role of small airway inflammation in asthma. Allergy Asthma Proc. 2002;23:233–242
  2. Kraft M. The distal airways: are they important in asthma?. Eur Respir J. 1999;14:1403–1417
  3. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1993;148:1220–1225
  4. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, et al. Inflammation of small airways in asthma. J Allergy Clin Immunol. 1997;100:44–51
  5. Kraft M, Martin RJ, Wilson S, Djukanovic R, Holgate ST. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med. 1999;159:228–234
  6. Bergeron C, Hauber HP, Gotfried M, Newman K, Dhanda R, Servi RJ, et al. Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide. J Allergy Clin Immunol. 2005;116:983–989
  7. Hauber HP, Gotfried M, Newman K, Danda R, Servi RJ, Christodoulopoulos P, et al. Effect of HFA-flunisolide on peripheral lung inflammation in asthma. J Allergy Clin Immunol. 2003;112:58–63
  8. Evans DJ, Coulby LJ, O'Connor BJ. Effect of allergen challenge on airway responsiveness to histamine and sodium metabisulphite in mild asthma. Thorax. 1996;51:1185–1191
  9. Machado L, Stalenheim G. Factors influencing the occurrence of late bronchial reactions after allergen challenge. Allergy. 1990;45:268–274
  10. Rasmussen JB. Late airway response increases at repeat allergen challenge. Allergy. 1991;46:419–426
  11. Peebles RS, Hamilton RG, Lichtenstein LM, Schlosberg M, Liu MC, Proud D, et al. Antigen-specific IgE and IgA antibodies in bronchoalveolar lavage fluid are associated with stronger antigen-induced late phase reactions. Clin Exp Allergy. 2001;31:239–248
  12. Sherter CB, Connolly JJ, Schilder DP. The significance of volume-adjusting the maximal midexpiratory flow in assessing the response to a bronchodilator drug. Chest. 1978;73:568–571
  13. McFadden ER, Holmes B, Kiker R. Variability of closing volume measurements in normal man. Am Rev Respir Dis. 1975;111:135–140
  14. Goldin JG, McNitt-Gray MF, Sorenson SM, Johnson TD, Dauphinee B, Kleerup EC, et al. Airway hyperreactivity: assessment with helical thin-section CT. Radiology. 1998;208:321–329
  15. Zeidler MR, Goldin J, Kleerup EC, Truong D, Simmons M, Kim HJ, et al. Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J. 2006;27:307–315
  16. Jarry G, DeMarco JJ, Beifuss U, Cagnon CH, McNitt-Gray MF. A Monte Carlo-based method to estimate radiation dose from spiral CT: from phantom testing to patient-specific models. Phys Med Biol. 2003;48:2645–2663
  17. ImPact CT dosimetry spreadsheet version 0.99u. London: Imaging Performance Assessment of CT scanners (ImPACT), St George Hospital. 2003. Available at: http://www.impactscan.org/ctdosimetry.htm. Accessed June 16, 2004.
  18. American Association for Respiratory Care . AARC clinical practice guideline: body plethysmography. Respir Care. 1994;39:1184–1190
  19. American Thoracic Society . Standardization of spirometry: 1994 update. Am J Respir Crit Care Med. 1995;152:1107–1136
  20. Martin R, Macklem P. Suggested standardization procedures for closing volume determination (nitrogen method). Bethesda (MD): Division of Lung Diseases, National Heart and Lung Institute; 1973;
  21. Popa V. ATS guidelines for methacholine and exercise challenge testing. Am J Respir Crit Care Med. 2001;163:292–293
  22. Corren J, Spector S, Fuller L, Minkwitz M, Mezzanotte W. Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure. Ann Allergy Asthma Immunol. 2001;87:211–217
  23. Pifferi M, Caramella D, Ragazzo V, Pietrobelli A, Boner AL. Low-density areas on high-resolution computed tomograms in chronic pediatric asthma. J Pediatr. 2002;141:104–108
  24. Goldin JG, Tashkin DP, Kleerup EC, Greaser LE, Haywood UM, Sayre JW, et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol. 1999;104:S258–S267
  25. in 't Veen JC, Beekman AJ, Bel EH, Sterk PJ. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 2000;161:1902-6.
  26. Ormstad H. Suspended particulate matter in indoor air: adjuvants and allergen carriers. Toxicology. 2000;152:53–68
  27. Luczynska CM, Li Y, Chapman MD, Platts-Mills TA. Airborne concentrations and particle size distribution of allergen derived from domestic cats (Felis domesticus): measurements using cascade impactor, liquid impinger, and a two-site monoclonal antibody assay for Fel d I. Am Rev Respir Dis. 1990;141:361–367
  28. Custovic A, Simpson A, Pahdi H, Green RM, Chapman MD, Woodcock A. Distribution, aerodynamic characteristics, and removal of the major cat allergen Fel d 1 in British homes. Thorax. 1998;53:33–38
  29. Swanson MC, Agarwal MK, Reed CE. An immunochemical approach to indoor aeroallergen quantitation with a new volumetric air sampler: studies with mite, roach, cat, mouse, and guinea pig antigens. J Allergy Clin Immunol. 1985;76:724–729
  30. Diaz-Sanchez D, Corren J, Nicodemus CF, Philip G. Cat room challenge and markers of upper and lower airways inflammation. [abstract] J Allergy Clin Immunol. 1998;101:A210
  31. Carroll N, James A. The distribution of inflammatory cells in the bronchial tree in fatal and nonfatal asthma. Am Rev Respir Dis. 1993;147:29S–30S
  32. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med. 1996;154:1505–1510
  33. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179–187
  34. Goldman HI, Becklake MR. Respiratory function tests: normal values at median altitudes and the prediction of normal results. Am Rev Tuberc. 1959;79:457–467
  35. Buist AS, Ross BB. Closing volume as a simple, sensitive test for the detection of peripheral airway disease. Chest. 1973;63(suppl):29S–30S

 Supported by Forest Pharmaceuticals.Disclosure of potential conflict of interest: E. C. Kleerup has received grant support from Forest; K. B. Newman is employed by Forest Labs; D. P. Tashkin has consultant arrangements with IVAX Pharmaceuticals, has received grant support from Merck and IVAX Pharmaceuticals, and is on the speakers bureau for IVAX Pharmaceuticals; J. Corren has received grant support from SPRI, AstraZeneca, Sepracor, GlaxoSmithKline, and Sky Pharma and is on the speakers bureau for SPRI and Sepracor. The rest of the authors have declared they have no conflict of interest.

PII: S0091-6749(06)01577-6

doi: 10.1016/j.jaci.2006.06.042

The Journal of Allergy and Clinical Immunology
Volume 118, Issue 5 , Pages 1075-1081 , November 2006

Article Tools

* Image Usage & Resolution